The United Kingdom's National Health Service begins a mass vaccination campaign against COVID-19 using the BNT162b2 vaccine developed by BioNTech and Pfizer. Seniors over the age of 80 and certain healthcare workers will be among the first to receive the vaccine.
The United Kingdom's National Health Service (NHS) begins a mass vaccination campaign against COVID-19 using the BNT162b2 vaccine developed by BioNTech and Pfizer. Over 80s and some healthcare workers are among the first to receive the vaccine.
The United Kingdom's National Health Service begins a mass vaccination campaign against COVID-19 using the BNT162b2 vaccine developed by BioNTech and Pfizer. Seniorsover theageof80 and certain healthcare workers willbe among the first to receive the vaccine.
